SCHEMBL13796983

SCHEMBL13796983

NCCNc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)nc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 15/20 0.56
▸ SLC6A4 P31645 2/20 0.56
▸ ADRA2A P08913 10/20 0.55
▸ MCHR1 Q99705 9/20 0.55
▸ AQP1 P29972 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ NPY1R P25929 1/20 0.49
▸ NPY2R P49146 1/20 0.49
▸ NPY4R P50391 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ TLR7 Q9NYK1 1/20 0.45
▸ BCDIN3D Q7Z5W3 1/20 0.44
▸ GBA1 P04062 1/20 0.42
▸ SOS1 Q07889 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13796979 0.94 NPY5R (0.54) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13796989 0.91 NPY5R (0.58) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13796446 0.90 NPY5R (0.60) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13796765 0.90 NPY5R (0.53) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13795423 0.90 NPY5R (0.56) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13796859 0.90 NPY5R (0.56) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13796960 0.89 NPY5R (0.59) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13796654 0.89 NPY5R (0.63) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13796267 0.88 NPY5R (0.55) NPY5RSLC6A4ADRA2AMCHR1AQP1
SCHEMBL13796850 0.88 NPY5R (0.51) NPY5RSLC6A4ADRA2AMCHR1AQP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544690-B2 MCH receptor antagonists TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-06-09 — — US disclosed
Send feedback